Cargando…
Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway
INTRODUCTION AND AIMS: The ASK1-JNK3 signaling pathway plays a pivotal role in the pathogenesis of Parkinson's disease (PD). The specific binding of β-arrestin2 to JNK3 is essential for activation of the ASK1-JNK3 cascade, representing a potential therapeutic target for preventing dopaminergic...
Autores principales: | Pan, Jing, Li, Hui, Zhang, Bei, Xiong, Ran, Zhang, Yu, Kang, Wen-Yan, Chen, Wei, Zhao, Zong-Bo, Chen, Sheng-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391862/ https://www.ncbi.nlm.nih.gov/pubmed/25856433 http://dx.doi.org/10.1371/journal.pone.0119204 |
Ejemplares similares
-
TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018) -
JNK Isoforms Differentially Regulate Neurite Growth and Regeneration in Dopaminergic Neurons In Vitro
por: Tönges, Lars, et al.
Publicado: (2011) -
Arrestin-3-assisted activation of JNK3 mediates dopaminergic behavioral and signaling plasticity in vivo
por: Ahmed, Mohamed R., et al.
Publicado: (2023) -
JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
por: Wang, Qing, et al.
Publicado: (2018) -
Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)